Recent Development in Therapeutic Cardiac Patches

Recent advances in (therapeutic protein) drug development

Therapeutic protein drugs are an important class of medicines serving patients most in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, autoimmunity/inflammation, exposure to infectious agents, and genetic disorders. The latest advances in protein-engineering technologies have allo...

Recent advances in cardiac development with therapeutic implications for adult cardiovascular disease.

Congenital heart disease (CHD) is the most common birth defect in humans, occurring as often as 1 in 125 live births.1,2 Because prenatal diagnosis and both medical and surgical care of affected neonatal infants have improved dramatically in the past decades, the number of adult survivors of CHD is increasing. Thus, it has become increasingly important for all cardiologists to be familiar with ...

Nanowired three dimensional cardiac patches

Engineered cardiac patches for treating damaged heart tissues after a heart attack are normally produced by seeding heart cells within three-dimensional porous biomaterial scaffolds. These biomaterials, which are usually made of either biological polymers such as alginate or synthetic polymers such as poly(lactic acid) (PLA), help cells organize into functioning tissues, but poor conductivity o...

Recent Development in Control of Threileria annulata in Iran

Recent insights into development, metabolic function and therapeutic potential